Impact of Smoking on Lung Cancer Chemoprevention
Impact of Smoking on Lung Cancer Chemoprevention
批准号:
6949040
负责人:
Waun Ki Hong
金额:
$172.88万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-08-20 至 2008-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant)
Lung cancer is the leading cause of cancer death among both men and women in
the United States today, and a rising public health problem throughout the
world. Although we?ve seen some improvement using combined modality
approaches, these have had little impact on survival.
Chemoprevention is a highly promising new approach that has already shown
enormous potential for the control of other epithelial solid tumors. However,
numerous studies of lung cancer chemoprevention have shown no benefit, and
some have shown actual harmful effects in current smokers. It seems clear
that previously unsuspected adverse interactions exist between tobacco
carcinogens and chemopreventive agents. Although further studies of lung
cancer chemoprevention are warranted, a thorough investigation of these
carcinogen/chemoprevention interactions is necessary before further
large-scale randomized trials are implemented.
The overall goals of this translational, multidisciplinary Program project are
to elucidate the interactions between tobacco carcinogens and chemopreventive
agents, investigate the potential of celecoxib for lung cancer
chemoprevention, and validate intermediate markers of lung carcinogenesis. To
accomplish our goals, we propose to carry out a clinical chemoprevention trial
in humans, while performing genetic, molecular, and pharmacologic studies to
understand the carcinogenic process and the interaction of carcinogens with
chemopreventive agents through the following projects:
Project 1: Clinical Trial of Celecoxib in Lung Cancer Chemoprevention
Project 2: Lung Cancer Prevention by COX-2 and 5-LOX Inhibitors, Retinoids,
and Their Combinations
Project 3: Molecular Alterations in Lung Carcinogenesis
Project 4: The Role of Transcription Factor NF-kB in Lung Cancer Development
and Chemoprevention
Core components (Administration, Biostatistics and Data Management, Histology,
and Pharmacology) are also included to provide the structure and expertise
required for the successful integration and execution of these studies.
期刊论文(135)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1158/1535-7163.mct-09-1113
发表时间:
2010-04
期刊:
Molecular cancer therapeutics
影响因子:
5.7
作者:
[Prasad S, Ravindran J, Sung B, Pandey MK, Aggarwal BB]
通讯作者:
Aggarwal BB
Inhibiting NF-κB activation by small molecules as a therapeutic strategy.
通过小分子抑制 NF-κB 激活作为治疗策略。
DOI:
10.1016/j.bbagrm.2010.05.004
发表时间:
2010-10
期刊:
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS
影响因子:
4.7
作者:
[Gupta, Subash C., Sundaram, Chitra, Reuter, Simone, Aggarwal, Bharat B.]
通讯作者:
Aggarwal, Bharat B.
Biological activity of celecoxib in the bronchial epithelium of current and former smokers.
塞来昔布在当前和前吸烟者的支气管上皮中的生物学活性。
DOI:
10.1158/1940-6207.capr-09-0233
发表时间:
2010-02
期刊:
Cancer prevention research (Philadelphia, Pa.)
影响因子:
--
作者:
[Kim ES, Hong WK, Lee JJ, Mao L, Morice RC, Liu DD, Jimenez CA, Eapen GA, Lotan R, Tang X, Newman RA, Wistuba II, Kurie JM]
通讯作者:
Kurie JM
DOI:
10.1158/1535-7163.mct-08-0905
发表时间:
2009-04
期刊:
Molecular cancer therapeutics
影响因子:
5.7
作者:
[Sung B, Kunnumakkara AB, Sethi G, Anand P, Guha S, Aggarwal BB]
通讯作者:
Aggarwal BB
DOI:
10.1158/1078-0432.ccr-13-1959
发表时间:
2014-04-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
[Gold KA, Kim ES, Liu DD, Yuan P, Behrens C, Solis LM, Kadara H, Rice DC, Wistuba II, Swisher SG, Hofstetter WL, Lee JJ, Hong WK]
通讯作者:
Hong WK
共 40 条
MD Anderson Cancer Center SPORE in Head and Neck Cancer
-
批准号:6665523
-
项目类别:
-
资助金额:$235.07万
-
财政年份:2002
-
负责人:Waun Ki Hong
-
依托单位:
MD Anderson Cancer Center SPORE in Head and Neck Cancer
-
批准号:7112910
-
项目类别:
-
资助金额:$237.65万
-
财政年份:2002
-
负责人:Waun Ki Hong
-
依托单位:
MD Anderson Cancer Center SPORE in Head and Neck Cancer
-
批准号:6531499
-
项目类别:
-
资助金额:$231.69万
-
财政年份:2002
-
负责人:Waun Ki Hong
-
依托单位:
MD Anderson Cancer Center SPORE in Head and Neck Cancer
-
批准号:6801959
-
项目类别:
-
资助金额:$235.16万
-
财政年份:2002
-
负责人:Waun Ki Hong
-
依托单位:
MD Anderson Cancer Center SPORE in Head and Neck Cancer
-
批准号:6951910
-
项目类别:
-
资助金额:$236.74万
-
财政年份:2002
-
负责人:Waun Ki Hong
-
依托单位:
Impact of Smoking on Lung Cancer Chemoprevention
-
批准号:6646587
-
项目类别:
-
资助金额:$163.93万
-
财政年份:2001
-
负责人:Waun Ki Hong
-
依托单位:
Impact of Smoking on Lung Cancer Chemoprevention
-
批准号:6793673
-
项目类别:
-
资助金额:$168.34万
-
财政年份:2001
-
负责人:Waun Ki Hong
-
依托单位:
Impact of Smoking on Lung Cancer Chemoprevention
-
批准号:6360029
-
项目类别:
-
资助金额:$158.47万
-
财政年份:2001
-
负责人:Waun Ki Hong
-
依托单位:
Impact of Smoking on Lung Cancer Chemoprevention
-
批准号:6522695
-
项目类别:
-
资助金额:$159.65万
-
财政年份:2001
-
负责人:Waun Ki Hong
-
依托单位:
CHEMOPREVENTION OF SECOND PRIMARY TUMORS WITH 13-CIS RETINOIC ACID
-
批准号:6300362
-
项目类别:
-
资助金额:$24.59万
-
财政年份:2000
-
负责人:Waun Ki Hong
-
依托单位:
CORE--BIOSTATISTICS AND DATA MANAGEMENT CORE
-
批准号:6218885
-
项目类别:
-
资助金额:$6.93万
-
财政年份:1999
-
负责人:Waun Ki Hong
-
依托单位:
CHEMOPREVENTION TRIAL IN FORMER SMOKERS
-
批准号:6218867
-
项目类别:
-
资助金额:$6.93万
-
财政年份:1999
-
负责人:Waun Ki Hong
-
依托单位:
BIOCHEMOPREVENTION THERAPY IN ADVANCED LARYNGEAL DYSPLAS
-
批准号:6174110
-
项目类别:
-
资助金额:$64.05万
-
财政年份:1998
-
负责人:Waun Ki Hong
-
依托单位:
CHEMOPREVENTION OF SECOND PRIMARY TUMORS WITH 13-CIS RETINOIC ACID
-
批准号:6102603
-
项目类别:
-
资助金额:$24.59万
-
财政年份:1998
-
负责人:Waun Ki Hong
-
依托单位:
CORE--BIOSTATISTICS AND DATA MANAGEMENT CORE
-
批准号:6103132
-
项目类别:
-
资助金额:$6.93万
-
财政年份:1998
-
负责人:Waun Ki Hong
-
依托单位:
CORE--BIOSTATISTICS AND DATA MANAGEMENT CORE
-
批准号:6269725
-
项目类别:
-
资助金额:$10.91万
-
财政年份:1998
-
负责人:Waun Ki Hong
-
依托单位:
BIOCHEMOPREVENTION THERAPY IN ADVANCED LARYNGEAL DYSPLAS
-
批准号:2896736
-
项目类别:
-
资助金额:$55.61万
-
财政年份:1998
-
负责人:Waun Ki Hong
-
依托单位:
CHEMOPREVENTION TRIAL IN FORMER SMOKERS
-
批准号:6269721
-
项目类别:
-
资助金额:$10.91万
-
财政年份:1998
-
负责人:Waun Ki Hong
-
依托单位:
BIOCHEMOPREVENTION THERAPY IN ADVANCED LARYNGEAL DYSPLAS
-
批准号:6513193
-
项目类别:
-
资助金额:$44.33万
-
财政年份:1998
-
负责人:Waun Ki Hong
-
依托单位:
BIOCHEMOPREVENTION THERAPY IN ADVANCED LARYNGEAL DYSPLAS
-
批准号:6376927
-
项目类别:
-
资助金额:$51.89万
-
财政年份:1998
-
负责人:Waun Ki Hong
-
依托单位: